Justin Hare, DO
Physical Medicine & Rehabilitation · Dalton, GANPI 1265790182
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 34.0% of the total. Reporting peaked in 2023 at $3,348 and has fallen 78.3% since, to $726 in 2025. Among physical medicine & rehabilitation clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $44.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Nalu Medical, Inc.$1K
- Abbott$683
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$310
- Forte Bio-pharma LLC$124
- plus $923 from 24 others
What the payments were for
- Travel & lodging$3,05044%
- Food & beverage$3,81755%
- Education$290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $2,345 |
| Boston Scientific | 14 | $1,345 |
| Nalu Medical, Inc. | 15 | $1,166 |
| Abbott | 32 | $683 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $310 |
| Forte Bio-pharma LLC | 6 | $124 |
| MML US, Inc. | 1 | $82 |
| Si-bone, Inc. | 3 | $76 |
| Saluda Medical Americas, Inc. | 3 | $68 |
| Foundation Fusion Solutions, LLC | 2 | $68 |
| Vertex | 2 | $66 |
| Collegium Pharmaceutical, Inc. | 4 | $59 |
| Pfizer | 4 | $54 |
| Amgen | 3 | $52 |
| Stryker | 1 | $52 |
| Johnson & Johnson | 1 | $39 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Valinor Pharma, LLC | 2 | $30 |
| Averitas Pharma Inc. | 1 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Painteq LLC | 1 | $26 |
| Merit Medical Systems Inc | 2 | $24 |
| Relievant Medsystems, Inc. | 1 | $20 |
| AbbVie | 1 | $19 |
| Siemens Medical Solutions USA, Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| SPR Therapeutics, Inc | 1 | $17 |
| Protega Pharmaceutials Inc | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,896 in reported general payments places this provider in the 90th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,331 | $227,119 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,828 | $95,617 |
| BelbucaBuprenorphine Hcl | 71 | $59,849 |
| MovantikNaloxegol Oxalate | 49 | $24,491 |
| Buprenorphine | 86 | $22,426 |
| Xtampza ErOxycodone Myristate | 35 | $17,789 |
| Oxycodone Hcl | 626 | $9,947 |
| Morphine Sulfate ErMorphine Sulfate | 276 | $7,683 |
| OxycontinOxycodone Hcl | 13 | $5,883 |
| Gabapentin | 657 | $5,723 |
| Pregabalin | 370 | $5,618 |
| LinzessLinaclotide | 11 | $5,571 |
| Morphine Sulfate | 129 | $4,172 |
| Lidocaine | 42 | $3,913 |
| Baclofen | 314 | $3,314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $59 | $77,638106 claims |
| AbbVieLinzess | $19 | $5,57111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 214 physical medicine & rehabilitation providers in Georgia.
Other physical medicine & rehabilitation in Dalton
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- Payal FadiaDecatur$66K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald ChaiLawrenceville$16K
- Gerald BilskyAtlanta$16K
- Aiwane IboayaColumbus$16K
- Joseph HegartyBaxley$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.